Aurora Cannabis (TSE:ACB) Price Target Raised to C$7.00

Aurora Cannabis (TSE:ACB) had its price target upped by ATB Cormark Capital Markets from C$5.60 to C$7.00 in a research note published on Tuesday,BayStreet reports. They currently have a tender rating on the stock.

ACB has been the topic of a number of other reports. TD decreased their target price on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Canaccord Genuity Group cut their price target on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. Finally, BMO Capital Markets raised shares of Aurora Cannabis to a “hold” rating in a research report on Wednesday, August 5th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Aurora Cannabis currently has an average rating of “Moderate Buy” and a consensus target price of C$6.67.

Aurora Cannabis Trading Down 0.8%

Shares of TSE:ACB opened at C$6.32 on Tuesday. Aurora Cannabis has a 52-week low of C$3.59 and a 52-week high of C$9.33. The company has a market capitalization of C$400.12 million, a P/E ratio of -3.26 and a beta of 0.64. The company has a 50-day simple moving average of C$5.33 and a 200 day simple moving average of C$4.75. The company has a debt-to-equity ratio of 4.30, a quick ratio of 2.48 and a current ratio of 5.36.

Aurora Cannabis (TSE:ACB) last announced its quarterly earnings results on Wednesday, August 5th. The company reported C($0.07) earnings per share for the quarter. The business had revenue of C$67.55 million for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%. Sell-side analysts forecast that Aurora Cannabis will post -0.22 earnings per share for the current year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.